41 – 50 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Using albumin to improve the therapeutic properties of diabetes treatments.
(
- Contribution to journal › Article
- 2011
-
Mark
Editorial: Long in the shade, glucagon re-occupies centre court
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
(
- Contribution to journal › Scientific review
-
Mark
Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)
(
- Contribution to journal › Article
-
Mark
Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.
(
- Contribution to journal › Article
-
Mark
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
(
- Contribution to journal › Article
-
Mark
The future of incretin-based therapy: novel avenues-novel targets.
(
- Contribution to journal › Article
- 2010
-
Mark
What ails the beta-cell?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A low glycaemic diet improves oral glucose tolerance but has no effect on β-cell function in C57BL/6J mice.
(
- Contribution to journal › Article